CU Medical's Operating Profit Reaches KRW 11.2 Billion Through Q3, Surpassing 2025 Full-Year Total View original image

CU Medical Systems, a company specializing in automated external defibrillators (AEDs), posted operating profit of KRW 11.2 billion on a non-consolidated basis through the third quarter of 2026, surpassing its full-year result for 2025. Driven by expanded overseas exports, both revenue and operating profit increased, and profitability improved.


CU Medical said on November 17 that it recorded revenue of KRW 36.9 billion and operating profit of KRW 11.2 billion on a non-consolidated basis in the first three quarters of 2026. Revenue rose 23% and operating profit increased 90% from the same period a year earlier. Cumulative operating profit had already exceeded the KRW 8.9 billion recorded for all of 2025.


The cumulative operating margin was 30.3%, up 10.6 percentage points from 19.6% in the same period a year earlier. CU Medical is an export-focused company that generates about 80% of its revenue overseas, and expanded overseas supply of its AED products contributed to its growth.


Growth continued on a consolidated basis as well. Cumulative revenue for the first three quarters was KRW 49 billion, while operating profit was KRW 10.7 billion, up 51% and 58%, respectively, from the same period a year earlier. Consolidated revenue surpassed the KRW 48.2 billion recorded for all of 2025 in just three quarters. VISTOS, a medical device company specializing in fetal and neonatal care whose management control CU Medical secured in January 2026, contributed KRW 9.8 billion to consolidated results.


In the third quarter, revenue on a non-consolidated basis was KRW 7.6 billion and operating profit was KRW 1.3 billion. Results declined from the same period a year earlier due to the timing of export shipments and foreign exchange movements, but the operating margin remained in double digits at 17.3%. Consolidated revenue for the third quarter rose 21% year over year to KRW 13.6 billion.



A CU Medical representative said, "Quarterly results vary depending on shipment timing, but on an annual basis, we are already on a growth trajectory that has surpassed last year's results. We will continue to grow in the fourth quarter as overseas supplies of our next-generation AED, the 'CU-SPX,' get fully underway and we realize synergies with VISTOS."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing